Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy.

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy. J Hematol Oncol. 2020 05 13; 13(1):50.

View in: PubMed